new clinical directions with abi‐009, a targeted nanoparticle mtor inhibitor
Published 7 years ago • 100 plays • Length 21:18Download video MP4
Download video MP3
Similar videos
-
16:21
novel clinical applications of abi‐009, an albumin‐bound mtor inhibitor
-
34:19
albumin bound sirolimus nanoparticles (abi-009) – early clinical studies
-
0:10
february 25, 2022
-
1:20
nanorobots detecting and treating cancer: professor hala zreiqat
-
0:30
mtor signaling pathway and mtor inhibitors in cancer: progress and challenges | rtcl.tv
-
0:42
mtor signaling pathway and mtor inhibitors in cancer: progress and challenges | rtcl.tv
-
18:30
intravenously injectable mrna‐lipoplex nanoparticles for tumor immunotherapy: clinical update...
-
2:01:21
9 late breaking and ongoing trials in nanomedicine and tageted delivery
-
18:01
multifunctional nanoparticle-based probes for cancer cells and biomarkers detection
-
0:57
dr. howard burris discusses the mtor inhibitor everolimus for breast cancer
-
2:09
the bull’s eye: new modified stem cells can deliver drugs specifically to tumor cells
-
6:08
neil desai -part3- abraxis bioscience
-
![nir-ii/mri nanoprobe for tnbc – video abstract [id 417944]](https://i.ytimg.com/vi/F9IgWxtsdHA/mqdefault.jpg)
2:58
nir-ii/mri nanoprobe for tnbc – video abstract [id 417944]
-
19:04
nanomedicine for target‐specific imaging and treatment of atherothrombosis
-
8:09
oncology & nuclear medicine －is advanced cancer treatable?
-
43:49
tumor molecular testing—making sense of new precision medicine testing options for cancer
-
59:44
applications in biomarker discovery and car t therapy using high-plex rna
-
33:47
towards robust and systematic translational systems for cancer therapeutic development
-
13:16
current and new pharmaceutical treatment options